Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

DiaMedica Therapeutics (DMAC) Receivables Refunds (2018 - 2021)

DiaMedica Therapeutics filings provide 4 years of Receivables Refunds readings, the most recent being $2000.0 for Q3 2021.

  • Quarterly Receivables Refunds changed N/A to $2000.0 in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $2000.0 through Sep 2021, changed N/A year-over-year, with the annual reading at $2000.0 for FY2020, 84.62% down from the prior year.
  • Receivables Refunds hit $2000.0 in Q3 2021 for DiaMedica Therapeutics, down from $4000.0 in the prior quarter.
  • Across five years, Receivables Refunds topped out at $134000.0 in Q4 2018 and bottomed at $2000.0 in Q4 2020.
  • Average Receivables Refunds over 4 years is $41400.0, with a median of $37500.0 recorded in 2020.
  • The largest annual shift saw Receivables Refunds plummeted 90.3% in 2019 before it tumbled 37.29% in 2020.
  • DiaMedica Therapeutics' Receivables Refunds stood at $134000.0 in 2018, then plummeted by 90.3% to $13000.0 in 2019, then tumbled by 84.62% to $2000.0 in 2020, then changed by 0.0% to $2000.0 in 2021.
  • Per Business Quant, the three most recent readings for DMAC's Receivables Refunds are $2000.0 (Q3 2021), $4000.0 (Q1 2021), and $2000.0 (Q4 2020).